OPK Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
OPKO Health Inc is not a good buy for a beginner, long-term investor at this moment. The company's financial performance is deteriorating, with significant YoY declines in revenue, net income, and EPS. While hedge funds are showing interest, there are no strong positive catalysts or technical signals supporting a buy decision. The stock's pre-market price is also declining, and analysts have lowered the price target, citing unsustainable revenue sources. For a beginner investor with a long-term focus, this stock does not align with the desired stability and growth potential.
The MACD is positive but contracting, RSI is neutral, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 1.201, with resistance at 1.247 and support at 1.155. Overall, the technical indicators do not suggest a strong buy signal.
Hedge funds are significantly increasing their positions, with a 1498.79% increase in buying over the last quarter.
The company's Q4 financials show a sharp decline in revenue (-19.16% YoY), net income (-322.83% YoY), and EPS (-300.00% YoY). Analysts have lowered the price target due to concerns about unsustainable revenue sources. Pre-market price is down 0.82%.
In 2025/Q4, OPKO Health reported a revenue drop of -19.16% YoY to $148.45M. Net income fell by -322.83% YoY to -$31.26M, and EPS dropped by -300% YoY to -0.04. Gross margin also declined to 30.29%, down -13.51% YoY.
Barrington lowered the price target from $2.25 to $1.50, maintaining an Outperform rating but expressing concerns about the sustainability of the company's performance.
